Filing exhibits
- 8-K/A Current report
- 23.1 Consent of Cohnreznick LLP
- 99.1 Audited Financial Statements of Cornerstone Pharmaceuticals, Inc. As of and for the Year Ended July 31, 2023
- 99.2 Unaudited Financial Statements of Cornerstone Pharmaceuticals, Inc. As of and for the Three Months Ended October 31, 2023
- 99.3 the Unaudited Proforma Condensed Combined Financial Statements of the Company
- Download Excel data file
- View Excel data file
Table of Contents